Delivery Order SPE2DB22D2006-SPE2DB25FV7MY

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Sumatriptan 20 mg nasal sprays. The firm-fixed-price delivery order, valued at $1,214.17, has an ultimate completion date of August 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,507.71 firm fixed-price delivery order is for the supply of 5 mg Sumatriptan nasal sprays, a medication used to treat migraine headaches. The award has an ultimate completion date of October 19, 2021 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,982.76 firm fixed-price delivery order is for the supply of 4,565,393 units of Sumatriptan 20 mg nasal sprays. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,288.60 Firm Fixed Price delivery order covers the procurement of 4,564,662,664 units of Sumatriptan 20 mg nasal sprays. The contract has an ultimate completion date of May 21, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award, valued at $2,057.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,576,146 units of Sumatriptan 20 mg nasal sprays, with a completion date of December 3, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,296,703 units of Sumatriptan 20 mg nasal sprays. The contract is a firm-fixed price delivery order with a ceiling value of $1,863.38 and a period of performance through July 31, 2024. This award is not associated with a set-aside program. Amerisourcebergen has been awarded numerous federal contracts by various defense and civilian...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,804,778 units of Sumatriptan 20 mg nasal sprays. The firm-fixed-price contract has a ceiling value of $2,055.07 and is set to expire on September 16, 2024. The contract is not associated with a set-aside program. Amerisourcebergen holds several indefinite delivery contracts (IDCs) with the DLA Troop Support Medical, valued...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4,565,879,554 units of 20 mg Sumatriptan nasal sprays. The $2,014.64 firm fixed-price award is part of a larger Indefinite Delivery Contract (IDC) that has a potential ceiling value of up to $999,999,999 and is used by the DLA to procure a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,854.85 delivery order is for the supply of 4,559,987,695 units of 20 mg Sumatriptan nasal sprays. The contract has a firm fixed price pricing type and a completion date of February 21, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of sumatriptan 20 mg nasal sprays. The contract has a ceiling value of $4,175.51 and a completion date of December 10, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV7MY
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,418.03 fixed-price contract is for the delivery of 4566892211 Sumatriptan 20 mg nasal sprays, a medication commonly used to treat migraines.

The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/13/25, 12:50 AM